Investigators at Dartmouth’s Geisel School of Medicine announced that two new studies of DAR-901, their investigational vaccine against tuberculosis (TB), have moved it to the forefront of new vaccines in development for global control of this deadly infectious disease.
Thanks to a collaboration between the pharmaceutical company MedImmune and Geisel structural biologist Jason McLellan, PhD, a long-awaited vaccine to protect infants from RSV may soon become a reality. Their findings are featured as this month’s cover story in the journal Science Translational Medicine.
Dartmouth medical alumnus Russell Andrews (MED ’78)—a neurosurgeon in California—has been part of a collaboration between NASA and the Mayo Clinic to develop a new wireless nanoelectrode that could help people with Parkinson’s disease.
Konstantin Dragnev, MD, a practicing oncologist at the Dartmouth-Hitchcock Norris Cotton Cancer Center and a translational scientist, has been named the Irene Heinz Given Professor in Pharmacology.
The Dean’s annual State of the Medical School presentation will be held on Wed., May 31 at 5:30 PM in Auditorium H at DHMC. Immediately following the presentation, the Geisel Academy of Faculty Master Educators will hold an induction ceremony for the group’s newest members. Video of event will be streamed live at https://video.dartmouth-hitchcock.org/ (under “Live Broadcast,” click on “Global Live Stream Channel 2). The broadcast will begin at 5:25 PM.